Hospital
George County Hospital
George County Hospital was paid $8.92M by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 12% of everything it billed.
33Billing provider infoGEORGE COUNTY HOSPITAL
LUCEDALE, MS 39452
LUCEDALE, MS 39452
33aNPI1023074028assigned 04/26/2006
33bProvider typeRural Acute Care Hospital
28Total paid$8.92M
24GClaims320,669
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,173 | $1.12M | |
| 2019 | 42,332 | $1.14M | |
| 2020 | 39,490 | $1.06M | |
| 2021 | 48,637 | $1.55M | |
| 2022 | 57,443 | $1.58M | |
| 2023 | 56,009 | $1.58M | |
| 2024incomplete | 31,585 | $895K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 15,031 | 12,834 | $1.11M |
| 59025 | Fetal non-stress test | 9.0% | 7,942 | 2,826 | $800K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.8% | 7,755 | 6,542 | $787K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 5.9% | 1,821 | 1,636 | $529K |
| G0378 | Hospital observation service, per hour | 5.2% | 1,378 | 1,141 | $461K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.1% | 13,689 | 11,751 | $458K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.6% | 20,927 | 2,672 | $318K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 4,197 | 3,306 | $315K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.2% | 2,837 | 2,415 | $289K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.8% | 1,801 | 1,558 | $254K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 4,947 | 4,083 | $201K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.2% | 2,612 | 2,389 | $193K |
134 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 2,739 | $190K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 1,895 | $142K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 10,785 | $139K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 4,796 | $136K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 3,940 | $134K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 3,121 | $131K |
| 76801 | 1.4% | 1,800 | $129K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.3% | 4,116 | $119K |
| 80053 | Comprehensive metabolic panel | 1.3% | 16,030 | $114K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 5,537 | $104K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 2,111 | $101K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 7,874 | $98K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 19,373 | $97K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.0% | 3,487 | $93K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,214 | $89K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,650 | $88K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,102 | $84K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 436 | $79K |
| 83880 | <1% | 3,389 | $71K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,457 | $63K |
| 73560 | <1% | 1,683 | $62K | |
| 72100 | <1% | 1,041 | $57K | |
| 73630 | <1% | 1,397 | $56K | |
| 97161 | <1% | 1,135 | $48K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,738 | $45K |
| 73030 | <1% | 1,180 | $41K | |
| 73610 | <1% | 906 | $39K | |
| 80061 | Lipid panel | <1% | 3,728 | $38K |
| 74018 | <1% | 743 | $34K | |
| 80305 | <1% | 3,818 | $33K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,486 | $32K |
| 81000 | <1% | 12,718 | $31K | |
| 84702 | <1% | 2,612 | $29K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 595 | $28K |
| 84484 | <1% | 3,552 | $27K | |
| 87088 | <1% | 4,551 | $25K | |
| 73110 | <1% | 511 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,395 | $23K |
| 81025 | <1% | 3,444 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,388 | $20K |
| 83655 | <1% | 1,788 | $20K | |
| 82553 | <1% | 3,341 | $18K | |
| 83735 | <1% | 4,701 | $18K | |
| 82550 | <1% | 3,602 | $15K | |
| 87807 | <1% | 1,367 | $15K | |
| 84144 | <1% | 913 | $13K | |
| 85730 | <1% | 3,757 | $12K | |
| 87428 | <1% | 278 | $12K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 357 | $11K |
| 87186 | <1% | 1,681 | $11K | |
| 85610 | <1% | 4,482 | $11K | |
| 82652 | <1% | 562 | $9K | |
| 87210 | <1% | 2,300 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 169 | $7K |
| 73502 | <1% | 223 | $7K | |
| 73130 | <1% | 151 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 34 | $6K |
| 86592 | <1% | 1,915 | $6K | |
| 85018 | <1% | 2,756 | $6K | |
| 85014 | <1% | 2,667 | $6K | |
| 83690 | <1% | 1,131 | $5K | |
| 82607 | <1% | 490 | $5K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 159 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 93 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 64 | $4K |
| 87040 | <1% | 333 | $4K | |
| 82947 | <1% | 1,075 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 55 | $3K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 271 | $3K |
| 83605 | <1% | 503 | $3K | |
| 99285 | Emergency room visit (most serious) | <1% | 29 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 15 | $2K |
| 74019 | <1% | 51 | $2K | |
| 0002A | <1% | 84 | $2K | |
| 0001A | <1% | 144 | $2K | |
| 81002 | <1% | 599 | $1K | |
| 83540 | <1% | 338 | $1K | |
| 83550 | <1% | 241 | $1K | |
| 87486 | <1% | 44 | $1K | |
| 72040 | <1% | 31 | $1K | |
| 84439 | <1% | 181 | $1K | |
| 87581 | <1% | 44 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 44 | $1K |
| 97010 | <1% | 339 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 17 | $1K |
| 86140 | <1% | 326 | $869.09 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $835.06 |
| 96367 | <1% | 25 | $668.96 | |
| 82950 | <1% | 130 | $582.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,317 | $521.07 |
| 82150 | <1% | 100 | $479.01 | |
| 85379 | <1% | 59 | $430.95 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,679 | $421.81 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,649 | $415.99 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 375 | $411.94 |
| 73562 | <1% | 14 | $367.51 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 976 | $360.85 |
| 87070 | <1% | 57 | $340.27 | |
| 85651 | <1% | 104 | $324.11 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,898 | $248.91 |
| 82043 | <1% | 55 | $222.71 | |
| 0011A | <1% | 15 | $213.50 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 571 | $208.66 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 19 | $186.69 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,309 | $184.15 |
| J3490 | Unclassified drugs | <1% | 2,457 | $181.40 |
| 84550 | <1% | 39 | $161.92 | |
| 86901 | <1% | 17 | $137.26 | |
| 82728 | <1% | 15 | $122.82 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 277 | $116.32 |
| 82951 | <1% | 12 | $115.46 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,969 | $112.13 |
| 83615 | <1% | 15 | $103.00 | |
| 82248 | <1% | 14 | $79.93 | |
| 84100 | <1% | 14 | $75.62 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,184 | $71.57 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,746 | $56.87 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,861 | $38.70 |
| 82570 | <1% | 15 | $37.38 | |
| 82952 | <1% | 12 | $35.20 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 69 | $1.69 |
| 96376 | 0% | 189 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 151 | $0.00 |
| L8699 | Prosthetic implant, not otherwise specified | 0% | 43 | $0.00 |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | 0% | 234 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 12 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 33 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 105 | $0.00 |
| 36591 | 0% | 16 | $0.00 | |
| 94760 | 0% | 26 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 274 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 207 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 127 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARDNER, PAUL (CEO)
| Provider | Location | Paid |
|---|---|---|
| George County Hospital | Leakesville, MS | $1.26M |
| Emerald Dental PLLC | Chattanooga, TN | $1.11M |
| George County Hospital- Crna | Lucedale, MS | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.